UBS Group AG - CINCOR PHARMA INC ownership

Back to all holdings Add to watchlist

CINCOR PHARMA INC's ticker is and the CUSIP is 17240Y109. A total of 54 filers reported holding CINCOR PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.8%.

Links
Filings
Quarter-by-quarter ownership
UBS Group AG ownership history of CINCOR PHARMA INC
ValueSharesWeighting
Q4 2022$4,618,754
+56.5%
375,814
+317.9%
0.00%
+100.0%
Q3 2022$2,952,000
+18350.0%
89,924
+10212.4%
0.00%–
Q2 2022$16,000
-57.9%
872
-59.5%
0.00%–
Q1 2022$38,000–2,155–0.00%–
 Download
Other shareholders
CINCOR PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CINCOR PHARMA INC shareholders